Navidea Biopharmaceuticals Stock Price

-0.0216 (-2.12%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 21,216
Bid Price
Ask Price
News -
Day High 1.0492


52 Week Range


Day Low 0.99
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Navidea Biopharmaceuticals Inc NAVB AMEX Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0216 -2.12% 0.9989 19:43:07
Open Price Low Price High Price Close Price Prev Close
1.02 0.99 1.0492 1.04 1.0205
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
216 21,216 $ 1.02 $ 21,595 - 0.93 - 3.15
Last Trade Time Type Quantity Stock Price Currency
20:00:00 346 $ 1.04 USD


Draw Mode:

Navidea Biopharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 30.16M 30.19M 19.73M $ 915.01k $ - -0.48 -2.60
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 391.03k 68.40%

more financials information »

Navidea Biopharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical NAVB Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.041.070.981.0151,377-0.0411-3.95%
1 Month1.161.270.981.0766,305-0.1611-13.89%
3 Months1.561.590.931.2266,743-0.5611-35.97%
6 Months1.801.860.931.4357,111-0.8011-44.51%
1 Year2.283.150.932.08155,762-1.28-56.19%
3 Years0.1365.35690.11311.82406,5630.8629634.49%
5 Years0.59015.35690.10011.20429,7210.408869.28%

Navidea Biopharmaceuticals Description

Navidea Biopharmaceuticals Inc is a biotechnology company specialized in precision medicine. Its products, precision immunodiagnostic agents and immunotherapeutic products are designed to assist in the identification of undetected diseases and to improve targeted treatment. The company's platform, known as Manocept technology, aims to develop next-generation targeted diagnostics and therapies for cancer, autoimmune conditions, and other inflammatory diseases. One of the company's products is Lymphoseek, a radioactive diagnostic agent indicated to locate lymph nodes.

Your Recent History
Navidea Bi..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.